XenoPort, Inc. news

   Watch this stock
Showing stories 1 - 2 of about 2   

Articles published

XNPT 7.07
price chart
Earnings Preview: Eli Lilly & Co
On June 7, 2012, Glaxosmithkline Plc and XenoPort, Inc. announced that the United States (US) Food and Drug Administration (FDA) has approved Horizant (gabapentin enacarbil) Extended-Release Tablets for the management of postherpetic neuralgia ...
Earnings Preview: Abbott Laboratories
Abbott Laboratories (ABT) engages in the discovery, development, manufacture, and sale of health care products worldwide. The company offers adult and pediatric pharmaceuticals for rheumatoid and psoriatic arthritis, ankylosing spondylitis, psoriasis, ...